14.01.2020 - 14:02 Uhr

PreveCeutical Announces Further Updates to the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program

PreveCeutical Medical Inc., CA74141E1043

DGAP-News: PreveCeutical Medical Inc.

/ Key word(s): Miscellaneous

PreveCeutical Announces Further Updates to the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program

14.01.2020 / 14:00

The issuer is solely responsible for the content of this announcement.

14.01.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: PreveCeutical Medical Inc.

Canada ISIN: CA74141E1043 EQS News ID: 953065   End of News DGAP News Service

953065  14.01.2020